Novo Holdings completes acquisition of US antibiotics company for DKK 3.2bn
Novo Nordisk Foundation’s investment company Novo Holdings has together with Gurnet Point Capital completed the acquisition of the American biotech company Paratek for USD 462m, including debt corresponding to DKK 3.2bn (USD 457.1m).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.